Tapentadol Spirig HC retard 25 mg
Tapentadol Spirig HC retard 25 mg is a medicine authorised by Swissmedic under authorisation number 68903. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 02 August 2023 and the authorisation is limited until 01 August 2028. ATC code N02AX06 places the medicine in the group Analgesics.
| Authorisation number | 68903 |
|---|---|
| Name | Tapentadol Spirig HC retard 25 mg |
| Full name | Tapentadol Spirig HC retard 25 mg, Retardtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AX06 |
| First authorisation | 02 August 2023 |
| Authorisation validity | 01 August 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tapentadol Spirig HC retard 25 mg, Retardtabletten | A+ | 02 August 2023 |
| 2 | Tapentadol Spirig HC retard 50 mg, Retardtabletten | A+ | 02 August 2023 |
| 3 | Tapentadol Spirig HC retard 100 mg, Retardtabletten | A+ | 02 August 2023 |
| 4 | Tapentadol Spirig HC retard 150 mg, Retardtabletten | A+ | 02 August 2023 |
| 5 | Tapentadol Spirig HC retard 200 mg, Retardtabletten | A+ | 02 August 2023 |
| 6 | Tapentadol Spirig HC retard 250 mg, Retardtabletten | A+ | 02 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 2 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 3 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 4 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 5 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 6 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 7 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 8 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 9 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 10 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 11 | 30 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 12 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tapentadol Spirig HC retard 25 mg authorised in Switzerland?
Yes. Tapentadol Spirig HC retard 25 mg is authorised by Swissmedic under authorisation number 68903, data as of 01 September 2026. The authorisation is limited until 01 August 2028.
Which dispensing category does Tapentadol Spirig HC retard 25 mg have?
Tapentadol Spirig HC retard 25 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Tapentadol Spirig HC retard 25 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.